Pacira Pharmaceuticals logo

Pacira Pharmaceuticals Share Price Today

(NASDAQ: PCRX)

Pacira Pharmaceuticals share price is $22.96 & ₹2,005.96 as on 4 Mar 2025, 2.30 'hrs' IST

$22.96

-1.09

(-4.53%)

Market is closed - opens 8 PM, 04 Mar 2025

View live Pacira Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Pacira Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pacira Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Pacira Pharmaceuticals share price movements

  • Today's Low: $22.80
    Today's High: $23.98

    Day's Volatility :4.9%

  • 52 Weeks Low: $11.16
    52 Weeks High: $31.67

    52 Weeks Volatility :64.75%

Pacira Pharmaceuticals (PCRX) Returns

PeriodPacira Pharmaceuticals, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
44.18%
1.4%
0.0%
6 Months
58.43%
-5.1%
0.0%
1 Year
-17.64%
1.8%
0.0%
3 Years
-66.22%
12.9%
-13.0%

Pacira Pharmaceuticals (PCRX) Key Statistics

in dollars & INR

Previous Close
$24.05
Open
$24.04
Today's High
$23.975
Today's Low
$22.8
Market Capitalization
$1.1B
Today's Volume
$1.7M
52 Week High
$31.67
52 Week Low
$11.164
Revenue TTM
$701.0M
EBITDA
$168.7M
Earnings Per Share (EPS)
$-2.15
Profit Margin
-14.2%
Quarterly Earnings Growth YOY
-0.38%
Return On Equity TTM
-12.08%

How to invest in Pacira Pharmaceuticals Stock (PCRX) from India?

It is very easy for Indian residents to invest directly in Pacira Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pacira Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pacira Pharmaceuticals or PCRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pacira Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pacira Pharmaceuticals shares which would translate to 0.038 fractional shares of Pacira Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pacira Pharmaceuticals, in just a few clicks!

Returns in Pacira Pharmaceuticals (PCRX) for Indian investors in Rupees

The Pacira Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pacira Pharmaceuticals investment value today

Current value as on today

₹84,062

Returns

₹15,938

(-15.94%)

Returns from Pacira Pharmaceuticals Stock

₹21,370 (-21.37%)

Dollar Returns

₹5,432 (+5.43%)

Indian investors sentiment towards Pacira Pharmaceuticals (PCRX)

25%

Period: Feb 1, 2025 to Mar 3, 2025. Change in 30 Days versus previous period

Search interest for Pacira Pharmaceuticals Stock from India on INDmoney has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Pacira Pharmaceuticals

  • BlackRock Inc

    16.70%

  • Vanguard Group Inc

    11.40%

  • Pacer Advisors, INC.

    7.07%

  • D. E. Shaw & Co LP

    4.89%

  • Renaissance Technologies Corp

    4.32%

  • State Street Corp

    4.26%

Analyst Recommendation on Pacira Pharmaceuticals

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Pacira Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
15
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Pacira Pharmaceuticals Stock (PCRX)

What analysts predicted

Upside of 24.44%

Target:

$28.57

Current:

$22.96

Insights on Pacira Pharmaceuticals Stock (Ticker Symbol: PCRX)

  • Price Movement

    In the last 3 months, PCRX stock has moved up by 44.2%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 168.57M → 187.25M (in $), with an average increase of 10.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -143.46M → 16.04M (in $), with an average increase of 994.4% per quarter
  • PCRX vs ITCI (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 79.3% return, outperforming this stock by 96.0%
  • PCRX vs ITCI (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 129.0% return, outperforming this stock by 195.4%
  • Price to Sales

    ForPCRX every $1 of sales, investors are willing to pay $1.6, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.4 for every $1 of sales.

Pacira Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Pacira Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Pacira Pharmaceuticals (PCRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pacira Pharmaceuticals, Inc. logo
-6.6%
58.43%
-17.64%
-66.22%
-41.78%
Intra-cellular Therapies, Inc. logo
0.79%
75.62%
90.69%
140.84%
486.46%
Haleon Plc Spon Ads logo
7.38%
0.2%
22.5%
37.38%
37.38%
Zoetis Inc. logo
-2.73%
-8.9%
-10.98%
-11.09%
19.83%
Neurocrine Biosciences Inc. logo
-20.91%
-5.1%
-10.82%
34.99%
24.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pacira Pharmaceuticals, Inc. logo
13.21
NA
-3.83
2.81
-0.12
0.04
NA
16.86
Intra-cellular Therapies, Inc. logo
NA
NA
0.0
0.18
-0.09
-0.07
NA
10.81
Haleon Plc Spon Ads logo
25.45
25.45
1.7
0.49
0.09
0.04
0.02
1.8
Zoetis Inc. logo
30.57
30.57
2.92
6.08
0.51
0.15
0.01
10.64
Neurocrine Biosciences Inc. logo
36.09
36.09
0.27
6.47
0.14
0.1
NA
26.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pacira Pharmaceuticals, Inc. logo
Buy
$1.1B
-41.78%
13.21
-14.2%
Intra-cellular Therapies, Inc. logo
Buy
$13.6B
486.46%
NA
-10.97%
Haleon Plc Spon Ads logo
Buy
$47.1B
37.38%
25.45
12.84%
Zoetis Inc. logo
Buy
$74.9B
19.83%
30.57
26.86%
Neurocrine Biosciences Inc. logo
Buy
$11.8B
24.93%
36.09
14.49%

About Pacira Pharmaceuticals

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Organization
Pacira Pharmaceuticals
Employees
0
CEO
Mr. Frank D. Lee
Industry
Health Technology

Management People of Pacira Pharmaceuticals

NameTitle
Ms. Kristen Williams J.D.
Chief Administrative Officer & Secretary
Mr. David M. Stack
Advisor
Mr. Charles A. Reinhart III, CPA, M.B.A.
Executive Officer
Dr. Jonathan Slonin M.D.
Chief Medical Officer
Mr. Frank D. Lee
CEO & Director
Mr. Shawn M. Cross
Chief Financial Officer
Ms. Lauren Bullaro Riker
Principal Accounting Officer & Senior VP of Finance
Ms. Susan Mesco
Head of Investor Relations
Mr. Anthony Molloy III, Esq.
Chief Legal & Compliance Officer
Mr. Christopher C. Young
Chief Manufacturing Officer

Important FAQs about investing in PCRX Stock from India :

What is Pacira Pharmaceuticals share price today?

Pacira Pharmaceuticals share price today stands at $22.96, Open: $24.04 ; Previous Close: $24.05 ; High: $23.98 ; Low: $22.80 ; 52 Week High: $31.67 ; 52 Week Low: $11.16.

The stock opens at $24.04, after a previous close of $24.05. The stock reached a daily high of $23.98 and a low of $22.80, with a 52-week high of $31.67 and a 52-week low of $11.16.

Can Indians buy Pacira Pharmaceuticals shares?

Yes, Indians can invest in the Pacira Pharmaceuticals (PCRX) from India.

With INDmoney, you can buy Pacira Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pacira Pharmaceuticals at zero transaction cost.

How can I buy Pacira Pharmaceuticals shares from India?

It is very easy to buy Pacira Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pacira Pharmaceuticals (PCRX) be purchased?

Yes, you can buy fractional shares of Pacira Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Pacira Pharmaceuticals stocks?

To start investing in Pacira Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pacira Pharmaceuticals Stock (PCRX)?

Today’s highest price of Pacira Pharmaceuticals (PCRX) is $23.98.

Today’s lowest price of Pacira Pharmaceuticals (PCRX) is $22.80.

What is today's market capitalisation of Pacira Pharmaceuticals?

Today's market capitalisation of Pacira Pharmaceuticals PCRX is 1.1B

What is the 52 Week High and Low Range of Pacira Pharmaceuticals Stock (PCRX)?

  • 52 Week High

    $31.67

  • 52 Week Low

    $11.16

What are the historical returns of Pacira Pharmaceuticals (PCRX)?

  • 1 Month Returns

    -6.6%

  • 3 Months Returns

    58.43%

  • 1 Year Returns

    -17.64%

  • 5 Years Returns

    -41.78%

Who is the Chief Executive Officer (CEO) of Pacira Pharmaceuticals ?

Mr. Frank D. Lee is the current Chief Executive Officer (CEO) of Pacira Pharmaceuticals.